BlackRock
CBST

BlackRock’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-582,621
Closed -$58.6M – 3229
2014
Q4 		$58.6M Buy
582,621
+566,919
+3,610% +$44.1M 0.08% 264
2014
Q3 		$1.04M Buy
15,702
+3,029
+24% +$199K ﹤0.01% 1201
2014
Q2 		$885K Sell
12,673
-5,882
-32% -$400K ﹤0.01% 1226
2014
Q1 		$1.36M Sell
18,555
-195
-1% -$14.5K ﹤0.01% 1134
2013
Q4 		$1.29M Buy
18,750
+481
+3% +$31.1K ﹤0.01% 1119
2013
Q3 		$1.16M Buy
18,269
+4,104
+29% +$248K ﹤0.01% 1055
2013
Q2 		$684K Buy
+14,165
New +$696K ﹤0.01% 1142

BlackRock's CBST Position: Q1 2015 in Review

BlackRock sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 582,621 shares — an estimated $58.6M sold.

BlackRock first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $58.6M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock sold 582,621 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $58.6M.
  • BlackRock first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock's CUBIST PHARMACEUTICALS INC position peaked at $58.6M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock's 13F filing for Q1 2015, filed 13 May 2015.